MSB 7.69% $1.19 mesoblast limited

RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-115

  1. 15,454 Posts.
    lightbulb Created with Sketch. 5535
    30,174 people have died in the USA from COVID-19 in the last 14 days


    If the NIH are indeed funding this additional COVID-19 ARDS trial using Remestemcel-L it makes you wonder why they are taking so long to get it started ? One would have to think the infrastructure is already in place given the multiple hospital sites used in the last trial ... I would have thought that it would have started by now so a little disappointing IMO


    https://www.worldometers.info/coronavirus/weekly-trends/#weekly_table

    upload_2022-1-28_9-42-8.png
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.